Diagnostic Tests

Krebs von den Lungen

LDT

ANTIGENS / BIOMARKERS

KL-6

SKU / TEST CODE

KL6

PROCEDURE / TECHNIQUE

-

REFERENCE RANGE

-

SENSITIVITY / SPECIFICITY

-

CLINICAL ASSOCIATIONS

Krebs von den Lungen-6 (KL-6) reflects the formation of fibrotic lung disease and is a biomarker used to characterize the risk and severity of interstitial lung diseases (ILDs). KL-6 is also a prognostic biomarker in patients with surgically resected non-small cell lung cancer.

Other Tests To Consider